About Aveta Biomics
Aveta Biomics is a private company based in Bedford, Massachusetts. It has reported $6,155,059 raised in three offerings on Form D since March 2018. Its chief executive is Parag Mehta.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 30, 2024 | Mar 19, 2025 | $4,455,040of $8.0M target | 36 | $123K | EquityRule 506(b) | Form D ↗ |
| Feb 8, 2022 | Feb 23, 2022 | $600,019of $5.0M target | 13 | $46,155 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 2, 2018 | Mar 19, 2018 | $1,100,000of $2.5M target | 4 | $275K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $6,155,059 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aveta Biomics's Form D filed Mar 19, 2025.
SK
S. P. Kothari
Director
PM
Parag Mehta
CEO and director
BT
Bharat Tewarie
Director
PD
Peter Dolan
Director
DP
David Page
Director
Earlier filings also listed Guha Bala (director, last listed Feb 2022), Sp Kothari (director, last listed Mar 2018) and Sharmila Mudgal (executive officer and director, last listed Mar 2018).